Follow on Google News News By Tag * Autoimmune Diseases * Therapeutics * Healthcare * Pharma * Demand Forecast * Market * Research * Report * Market Forecast * Market Share * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Competitive Benchmarking on Autoimmune Diseases TherapeuticsBharatbook.com added a new report on " The Future of Autoimmune Diseases Therapeutics " provides in-depth analysis of unmet needs, drivers and barriers that impact the global autoimmune diseases therapeutics market.
By: Bharat Book Bureau Summary “The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global autoimmune diseases therapeutics market. The report analyzes the markets for autoimmune disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. ( http://www.bharatbook.com/ Scope The scope of this report includes: - Annualized market data for the autoimmune diseases therapeutics market from 2000 to 2008, forecast forward to 2015 - Analysis of the leading therapeutic segments including rheumatoid arthritis, multiple sclerosis, systemic lupus, erythematosus, crohn’s disease and ulcerative colitis - Analysis of the autoimmune diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization of the autoimmune diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns - Key drivers and barriers that have a significant impact on the market - Coverage of pipeline molecules in various phases of drug development - Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Amgen Inc, AstraZeneca, Merck & Co, Pfizer Inc, Celgene Corporation, Bristol-Myers Squibb and Eli Lilly - Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global autoimmune diseases therapeutics market Reasons to buy The report will enhance your decision making capability. It will allow you to - Align product portfolio to the markets with high growth potential - Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety - Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/ Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/ # # # Bharat Book Bureau is the leading business information aggregator providing market research reports and online databases. Bharatbook is also into the business of marketing conferences worldwide and undertakes custom research. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|